EUVIMED · CrossrefZeitschrift
Respiratory Medicine: COPD Update
ISSN 1745-0454 · Elsevier BV
Neueste Artikel
Respiratory Medicine: COPD Update—a new journal
Literature reviews
COPD management—a hospital physician's view
The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review
COPD: Challenges and opportunities for primary care
EDITORIAL
Domiciliary oxygen therapy in COPD
Smoking reduction and the rate of decline in FEV1: Results from the Lung Health Study
Predictors of smoking reduction without formal intervention
Relation between duration of smoking cessation and bronchial inflammation in COPD
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease
Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers
Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs
Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke
Long-term reduction of hyperinflation in stable COPD by non-invasive nocturnal home ventilation
Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnea at rest and during exercise in COPD
Changes in respiratory mechanics with increasing degrees of airway obstruction in COPD: Detection by forced oscillation technique
Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD
Roflumilast—An oral anti-inflammatory treatment for chronic obstructive pulmonary disease: A randomised controlled trial
First study of infliximab treatment in patients with chronic obstructive pulmonary disease
Inhaled corticosteroids in chronic obstructive pulmonary disease: Results from two observational designs free of immortal time bias
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial
Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: A randomised controlled trial
Heliox improves hemodynamics in mechanically ventilated patients with chronic obstructive pulmonary disease with systolic pressure variations
Inhaled corticosteroids and survival in COPD patients receiving long-term home oxygen therapy
Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease
Body composition and mortality in chronic obstructive pulmonary disease
EUVIMED